MedTrace Logo

Understanding COVID-19

NCT04329546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2022-05-24

No results posted yet for this study

Summary

This single-center prospective observational study will examine immune responses to to SARS-CoV-2 and how they correlate with its virological characteristics and clinical manifestations in infected patients. Household contacts will also be included so that early immune responses and viral kinetics can be captured. Patients and contacts will be followed for 8 and 2 weeks, respectively. The study will include a maximum of 250 participants.

Conditions

  • SARS-CoV-2 Viral Kinetics and Host Immune Responses

Interventions

OTHER

NA (no intervention)

NA (no intervention)

Sponsors & Collaborators

  • University of Geneva, Switzerland

    collaborator OTHER

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Claire-Anne Siegrist, MD · Professor of vaccinology

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-27
Primary Completion
2021-10-31
Completion
2021-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04329546 on ClinicalTrials.gov